The overexpression of MEK5 could be used as an effective additional tool in identifying those CRC patients at increased risk of tumor invasiveness, metastasis, or differentiation grade, and knock down of MEK5 led to significantly inhibiting the malignant phenotype of colon cancer cells in vitro an vivo. The gene discussed is MAP2K5; the disease is neoplasm.